Filters

Indometacin manufacturers

Filters

Filters

Filters , active

Country of origin : India
None products found

indometacin

Capsules 25 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #19316
This pharmaceutical company specializes in both over-the-counter (OTC) and prescription generic drugs, offering products in the form of tablets, capsules, and liquids. Founded in 1992, they initially focused on the US market before expanding globally. They hold a significant distinction as the first Indian company to receive USFDA approvals for producing both OTC and prescription drugs for the US market. Their manufacturing facility is located in India, with a dedicated marketing and distribution center in the USA. Key therapy areas are not specified, nor are details about specific product patents or GMP certifications provided.

Manufacturer usually replies in 19 days

indometacin

Solution for injection 1 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #2303
A pharmaceutical manufacturer with over 25 years of experience that develops and produces fixed-dose and single-entity generic and specialty pharmaceutical products. The company offers an extensive range of injectable dosage forms, including parenterals, and also manufactures oral solids. Its facilities operate under recognised international quality certifications such as EU-GMP, ANVISA, PIC/S and TGA approvals, supporting reliable large-scale production of pharmaceutical products for global export while emphasizing efficacy, affordability and consistent quality.

Manufacturer usually replies in 23 days

indometacin

Capsules 25 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
Canada, United Kingdom, TGA, WHO
Manufacturer #18229
India-based pharmaceutical company focused on producing and supplying generic Rx formulations for domestic and international markets. Solid and liquid oral dosage forms cover essential and specialty therapy areas in alignment with Indian GMP standards. Committed to regulatory compliance and quality manufacturing for domestic and export requirements.

Manufacturer usually replies in 54 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Indometacin

Indometacin is a nonsteroidal anti-inflammatory drug, that has analgesic, anti-inflammatory, and antipyretic properties. It is also called indomethacin. It is used to reduce fever, pain, stiffness, and swelling caused by inflammation. Its actions inhibit the production of prostaglandins, endogenous signaling molecules associated with the symptoms. Indometacin inhibits cyclooxygenase, the enzyme responsible for catalyzing the production of prostaglandins. As such it is used to treat Joint diseases like rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, gouty arthritis, acute painful shoulder bursitis or tendinitis, Headaches, Trigeminal autonomic cephalgias, Paroxysmal hemicranias, Chronic paroxysmal hemicrania, Episodic paroxysmal hemicrania, Hemicrania continua, Valsalva-induced headaches, Primary cough, headache, Primary exertional headache, Primary headache associated with preorgasmic and orgasmic Primary stabbing headache, Hypnic headache and some others. Indometacin is sold under the brand names Indocin, Indocin SR, Tivorbex among others. Union Carbide Corp patented it in 1961 and was approved for sales in 1963. However, after the expiry of initial patent protection, it is now marketed under more than twelve different brands. In 2017 alone, it was prescribed to 1 million US citizens.

Dosage and administration

Indometacin is available as immediate-release tablets of 25-50 mg, which can be administered orally or rectally, as an Extended release of 75-150 mg a day, orally in a single daily dose or every 12 hours. The daily dose cannot exceed 150 mg a day. In the treatment of Bursitis or Tendinitis, the dose if using Immediate-release tablet, is 75-150 mg per day administered given every 6 to 8 hours or if taking Extended-release tablet, the dose is 75-150 mg a day, taken orally in single daily dose or every 12 hours. In the treatment of Acute Gouty Arthritis, the dose is 50 mg, taken orally or inserted rectally for 3-5 days, and reduced once pain control has been achieved. In the treatment of Nephrogenic Diabetes Insipidus, the dose is 2 mg per kilo per day, taken orally every 8 hours. For mild-to-moderate acute pain, the dose is 20 mg taken orally three times a day or 40 mg taken orally, 2 or 3 times a day.

The Price of Indometacin

In the USA, the average retail price of 30 capsules of 50mg cost around $15.30. Indometacin is much cheaper in developing parts of the world, where it is made and sold by generic drug makers. In India, the price of a 25mg tablet is USD 0.28

How does it work?

Indometacin, as a nonsteroidal anti-inflammatory drug with analgesic, anti-inflammatory, and antipyretic properties. Its actions inhibit the production of prostaglandins, endogenous signaling molecules that causes these symptoms.

Finding Indometacin Manufacturers and Suppliers:

The process of finding trusted Indometacin manufacturers and Indometacin suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B a marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. In addition, it is an easy-to-use online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Indometacin. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.